Session 1: Reconsidering the optimization of first-line treatment strategies in locally advanced or metastatic urothelial cancer
Release date: 30-04-2024
Expiration date: 29-04-2025
Opening & Keynote Speech: First-line treatment decision-making for unresectable locally advanced or metastatic (LA/m) urothelial cancer (UC)
Enrique Grande, MD, MSc, PhD
MD Anderson Cancer Center Madrid
Madrid, Spain
-
Opening & Keynote Speech: First-line treatment decision-making for unresectable locally advanced or metastatic (LA/m) urothelial cancer (UC)
Enrique Grande, MD, MSc, PhD
-
Case 1: First-line treatment with maintenance immunotherapy for a platinum-eligible patient & Case 2: First-line treatment with mono-immunotherapy for a cisplatin-ineligible patient
Joachim Chan, BSc, MBBS, MRCP, FRCR, MD
-
Panel Discussion & Pearls for Practice
Fernando Maluf, MD, PhD